TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,290
|
1,292
|
1,886 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
362
|
219
|
794 |
| EBITDA |
359
|
219
|
794 |
| Total assets |
2,191
|
2,386
|
2,349 |
| Current assets |
2,191
|
2,386
|
2,349 |
| Current liabilities |
15
|
195
|
30 |
| Equity capital |
2,110
|
2,125
|
2,253 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
96.3%
|
89.1%
|
95.9% |
| Turnover per employee |
1,290
|
1,292
|
1,886 |
| Profit as a percentage of turnover |
28.1%
|
17.0%
|
42.1% |
| Return on assets (ROA) |
16.5%
|
9.2%
|
33.8% |
| Current ratio |
14606.7%
|
1223.6%
|
7830.0% |
| Return on equity (ROE) |
17.2%
|
10.3%
|
35.2% |
| Change turnover |
-2
|
-594
|
-173 |
| Change turnover % |
0%
|
-31%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.